1Department of Immunology, School of Medicine,UConn Health, 2Center for Molecular Discovery,University of New Mexico Health Sciences Center, 3Comprehensive Cancer Center,University of New Mexico Health Sciences Center, 4Department of Pathology,University of New Mexico Health Sciences Center, 5Autophagy, Inflammation, & Metabolism (AIM) Center,University of New Mexico
Questo protocollo descrive un metodo di screening ad alto rendimento basato sulla citometria a flusso per identificare farmaci a piccole molecole che inibiscono l’attivazione dell’integrina β2 sui neutrofili umani.
